Question

Dr. Jitendra Singh announced the soft launch of India's first indigenous antibiotic, Nafithromycin, in November 2024. This antibiotic offers how many times more efficacy compared to azithromycin, with just three doses?

• A. 3x
• B. 7x
• C. 10x
• D. 5x

Answer 1

Answer:

C. 10x

The Nafithromycin antibiotic offers 10 times more efficacy compared to azithromycin, with just three doses. This groundbreaking antibiotic is ten times more effective than current treatments like azithromycin and offers a three-day treatment regimen, significantly shortening the recovery time while improving patient outcomes. Antimicrobial resistance has long been a growing global concern, with pharmaceutical companies striving to develop new medicines to combat it worldwide. Despite years of challenges and relentless effort, a breakthrough has finally emerged. After three decades of research and hard work, India has led the way with the creation of Nafithromycin, the country’s first indigenous Macrolide antibiotic. This remarkable achievement marks a pivotal moment in the fight against antimicrobial resistance, showcasing India’s growing capabilities in pharmaceutical innovation.